|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
39,300,000 |
Market
Cap: |
19.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $3.1 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CohBar is a clinical stage biotechnology company utilizing the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. In addition, Co. has multiple preclinical programs, such as a program in acute respiratory distress syndrome as well as earlier stage discovery programs. Co.'s pipelines include: CB5138-3, which is for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases; CB4211, which is for the treatment of nonalcoholic steatohepatitis and obesity; and CB5064 Analogs, family of peptides that are agonists of the apelin receptor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Allen Simon |
Chief Executive Officer |
|
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,200 |
|
- |
|
Allen Simon |
Chief Executive Officer |
|
2017-01-31 |
4 |
S |
$1.89 |
$276 |
I/I |
(135) |
0 |
|
- |
|
Allen Simon |
Chief Executive Officer |
|
2017-01-31 |
4 |
B |
$2.30 |
$460 |
D/D |
200 |
200 |
2.66 |
- |
|
Allen Simon |
Chief Executive Officer |
|
2017-01-31 |
4 |
B |
$2.48 |
$335 |
I/I |
135 |
135 |
1.91 |
- |
|
Fitzgerald Albion |
Director |
|
2016-11-08 |
4 |
OE |
$2.00 |
$500,000 |
D/D |
250,000 |
1,768,000 |
|
- |
|
Stern Jon Leland |
Chief Operating Officer |
|
2016-11-03 |
4 |
OE |
$2.00 |
$150,000 |
D/D |
75,000 |
508,000 |
|
- |
|
Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
|
2015-11-19 |
4 |
B |
$1.16 |
$290 |
I/I |
250 |
1,000 |
1.91 |
- |
|
Barzilai Nir Yacov |
Director |
|
2015-06-01 |
4 |
B |
$0.94 |
$4,700 |
D/D |
5,000 |
5,044,516 |
3.84 |
- |
|
Cohen Pinchas |
Director |
|
2015-06-01 |
4 |
B |
$1.15 |
$5,750 |
D/D |
5,000 |
5,449,703 |
3.84 |
- |
|
Fitzgerald Albion |
Director |
|
2015-05-26 |
4 |
B |
$0.97 |
$4,365 |
D/D |
4,500 |
1,518,000 |
2.31 |
- |
|
Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
|
2015-05-26 |
4 |
B |
$0.98 |
$735 |
I/I |
750 |
750 |
1.91 |
- |
|
Fitzgerald Albion |
Director |
|
2015-05-22 |
4 |
B |
$0.97 |
$2,910 |
D/D |
3,000 |
1,513,500 |
2.31 |
- |
|
Cundy Kenneth C |
Chief Scientific Officer |
|
2015-05-22 |
4 |
B |
$1.00 |
$10,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Biunno Jeffrey Francis |
CFO, Treasurer and Secretary |
|
2015-05-22 |
4 |
B |
$0.95 |
$1,900 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
Fitzgerald Albion |
Director |
|
2015-05-21 |
4 |
B |
$0.95 |
$5,700 |
D/D |
6,000 |
1,510,500 |
2.39 |
- |
|
Fitzgerald Albion |
Director |
|
2015-05-20 |
4 |
B |
$0.97 |
$4,365 |
D/D |
4,500 |
1,504,500 |
2.31 |
- |
|
Stern Jon Leland |
Chief Executive Officer |
|
2015-05-20 |
4 |
B |
$0.98 |
$4,900 |
D/D |
5,000 |
455,000 |
2.73 |
- |
|
Stern Jon Leland |
Chief Executive Officer |
|
2015-01-06 |
4 |
B |
$0.00 |
$0 |
D/D |
150,000 |
450,000 |
2.73 |
- |
|
Stern Jon Leland |
Chief Executive Officer |
|
2015-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
|
- |
|
Fitzgerald Albion |
Director |
|
2015-01-06 |
4 |
B |
$0.00 |
$0 |
D/D |
500,000 |
1,500,000 |
2.31 |
- |
|
Fitzgerald Albion |
Director |
|
2015-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
|
- |
|
Cohen Pinchas |
Director |
|
2014-12-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,444,703 |
|
- |
|
Barzilai Nir Yacov |
Director |
|
2014-12-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,039,516 |
|
- |
|
98 Records found
|
|
Page 4 of 4 |
|
|